Midazolam Nasal Spray 2.5 mg, 5 mg, 7.5 mg, 10 mg Suppliers & Bulk Manufacturers
Available Forms: Nasal/Buccal
Available Strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg
Reference Brands: Nayzilam (nasal spray)(US)
Category: Antipsychotropic Drugs
Midazolam is a benzodiazepine used for sedation, anesthesia, and seizure management. Available in injectable, nasal, and oral forms, it's marketed as Versed in the US and Buccolam in the EU. A critical ICU and emergency drug, Midazolam is a key product for pharma B2B distributors and hospital suppliers.
Product Description:
Midazolam is a fast-acting benzodiazepine used for sedation, anesthesia induction, and seizure control. Available in various forms like injections (1 mg/mL, 5 mg/mL), oral syrup, nasal spray, and buccal solutions, it is widely used in ICU and emergency settings. In the US, it is marketed under brands like Versed and Nayzilam, while in the EU, Buccolam and Epistatus are common. Midazolam is a high-demand product in hospital and ambulatory care, making it a vital listing for pharmaceutical B2B platforms dealing in anesthesia, emergency care, and neurology segments.
Midazolam Nasal Spray — third party manufacturing & bulk supply
Midazolam Nasal Spray 2.5 mg, 5 mg, 7.5 mg, 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Midazolam Nasal Spray listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Midazolam Nasal Spray →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Midazolam nasal spray is used for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity, also known as seizure clusters or acute repetitive seizures, in patients with epilepsy. It is designed for rapid administration through the nose to quickly control seizures outside of a hospital setting.
Midazolam nasal spray is made from the active pharmaceutical ingredient midazolam hydrochloride. It belongs to the benzodiazepine class of medicines and works by enhancing the effect of gamma-aminobutyric acid (GABA), a neurotransmitter that helps calm excessive electrical activity in the brain.
The main trade name in the United States is Nayzilam. In Europe and the United Kingdom, midazolam is commonly available as Buccolam in an oromucosal (buccal) formulation.
Nayzilam is marketed by UCB Inc. Buccolam is marketed by Neuraxpharm in several European countries.
The generic name is midazolam hydrochloride.
The brand name in the USA is Nayzilam. In Europe and the UK, it is available as Buccolam (buccal formulation).
Midazolam nasal spray products are manufactured in GMP-certified pharmaceutical facilities in the United States and Europe, depending on the brand owner and marketing authorization holder. Specific manufacturing locations may vary by region and batch.
Related Products
Lithium Carbonate
Strength:
150 mg, 300 mg, 600 mg
Form: Tablets
Reference Brands: Lithobid (USA/LATAM), Priadel (EU)
View Details
Phenobarbital Sodium
Strength:
65 mg/mL, 130 mg/mL.
Form: Injection
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
